Miniaturized chromatographic systems for radiochemical purity evaluation of 131I-Ferulic acid as a new candidate in nuclear medicine applications

Recently, the anticancer activity of ferulic acid (FA) which is a caffeic acid derivative has been reported. Therefore, in this study FA was radiocaped with 131I− to explore its potential as a tumor targeting agent. The radiolabeling process was carried out via electrophilic substitution reaction. T...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Applied radiation and isotopes 2021-01, Vol.167, p.109370-109370, Article 109370
Hauptverfasser: Sedik, Ghada A., Rizq, R.S. Abo, Ibrahim, I.T., Elzanfaly, E.S., Motaleb, M.A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 109370
container_issue
container_start_page 109370
container_title Applied radiation and isotopes
container_volume 167
creator Sedik, Ghada A.
Rizq, R.S. Abo
Ibrahim, I.T.
Elzanfaly, E.S.
Motaleb, M.A.
description Recently, the anticancer activity of ferulic acid (FA) which is a caffeic acid derivative has been reported. Therefore, in this study FA was radiocaped with 131I− to explore its potential as a tumor targeting agent. The radiolabeling process was carried out via electrophilic substitution reaction. The factors affecting labeling yield were optimized and the radiochemical purity (RCP) was assessed by various analytical techniques including paper chromatography (PC), thin layer chromatography (TLC), instant thin layer chromatography (ITLC), paper electrophoresis (PE) and high-performance liquid chromatography (HPLC). The RCP assay was extended to the utilization of miniaturized techniques including miniaturized PC (mini-PC), mini-TLC and mini-column chromatography (silica, sephadex-G25). Validation of mini-TLC, as one of 131I-FA RCP assay methods, was done according to ICH guidelines. Biodistribution studies of 131I-FA were performed on Ehrlich solid tumor bearing mice at various time points (5, 30, 60, 120 and 240 min), post injection. The radiolabeling yield of 131I-FA was 96.23 ± 0.45% and the miniaturized chromatographic systems showed high efficacy in RCP evaluation comparable to the conventional ones. Mini-TLC was proved to be specific, accurate, precise and linear. The tumor uptake of 131I-FA in solid tumor bearing mice was 4.35 ± 0.41 ID/g at 60 min with 2.79 as a tumor/muscle ratio. Consequently, 131I-FA could be used as a tumor targeting agent for nuclear medicine applications and the fast reaction monitoring could be achieved using miniaturized chromatographic techniques. •Cancer is a class of diseases designated by uncontrolled cell growth.•For cancer treatment, different therapies are available. Chemotherapy and radiotherapy are the most common ones.•New trends to discover natural alternative therapies, especially from plants, are applied for cancer treatment.•Ferulic acid was radiocaped with 131I− to explore its potential as a tumor targeting agent of plant origin.•Assessment of the radiochemical purity using miniaturized chromatographic techniques.
doi_str_mv 10.1016/j.apradiso.2020.109370
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2451846232</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0969804320305170</els_id><sourcerecordid>2451846232</sourcerecordid><originalsourceid>FETCH-LOGICAL-c275t-f60ae3d70cb8da159150d957eab882e3ef435fda9a72b21d0694be9bb112c28a3</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EEkvhLyAfuWSxnS_7BqpoqdSqFzhbE3vCziqxg-0ULf-Cf0yWhTOnkUbv845GD2NvpdhLIbv3xz0sCTzluFdCnZem7sUztpO6V5XRQjxnO2E6U2nR1C_Zq5yPQohGG7Vjvx4oEJQ10U_03B1SnKHEbwmWAzmeT7ngnPkYEz-fiO6AMzmY-LIR5cTxCaYVCsXA48hlLe-qG0zrtLHgyHPIHHjAH9xB8OShIKfAw-omhMRn9OQoIIdl2ZA_Pfk1ezHClPHN33nFvt58-nL9ubp_vL27_nhfOdW3pRo7AVj7XrhBe5Ctka3wpu0RBq0V1jg2dTt6MNCrQUkvOtMMaIZBSuWUhvqKvbv0Lil-XzEXO1N2OE0QMK7ZqqaVuulUrbZod4m6FHNOONol0QzpZKWwZwf2aP85sGcH9uJgAz9cQNweeSJMNjvC4La_E7pifaT_VfwGXZSW7g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2451846232</pqid></control><display><type>article</type><title>Miniaturized chromatographic systems for radiochemical purity evaluation of 131I-Ferulic acid as a new candidate in nuclear medicine applications</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Sedik, Ghada A. ; Rizq, R.S. Abo ; Ibrahim, I.T. ; Elzanfaly, E.S. ; Motaleb, M.A.</creator><creatorcontrib>Sedik, Ghada A. ; Rizq, R.S. Abo ; Ibrahim, I.T. ; Elzanfaly, E.S. ; Motaleb, M.A.</creatorcontrib><description>Recently, the anticancer activity of ferulic acid (FA) which is a caffeic acid derivative has been reported. Therefore, in this study FA was radiocaped with 131I− to explore its potential as a tumor targeting agent. The radiolabeling process was carried out via electrophilic substitution reaction. The factors affecting labeling yield were optimized and the radiochemical purity (RCP) was assessed by various analytical techniques including paper chromatography (PC), thin layer chromatography (TLC), instant thin layer chromatography (ITLC), paper electrophoresis (PE) and high-performance liquid chromatography (HPLC). The RCP assay was extended to the utilization of miniaturized techniques including miniaturized PC (mini-PC), mini-TLC and mini-column chromatography (silica, sephadex-G25). Validation of mini-TLC, as one of 131I-FA RCP assay methods, was done according to ICH guidelines. Biodistribution studies of 131I-FA were performed on Ehrlich solid tumor bearing mice at various time points (5, 30, 60, 120 and 240 min), post injection. The radiolabeling yield of 131I-FA was 96.23 ± 0.45% and the miniaturized chromatographic systems showed high efficacy in RCP evaluation comparable to the conventional ones. Mini-TLC was proved to be specific, accurate, precise and linear. The tumor uptake of 131I-FA in solid tumor bearing mice was 4.35 ± 0.41 ID/g at 60 min with 2.79 as a tumor/muscle ratio. Consequently, 131I-FA could be used as a tumor targeting agent for nuclear medicine applications and the fast reaction monitoring could be achieved using miniaturized chromatographic techniques. •Cancer is a class of diseases designated by uncontrolled cell growth.•For cancer treatment, different therapies are available. Chemotherapy and radiotherapy are the most common ones.•New trends to discover natural alternative therapies, especially from plants, are applied for cancer treatment.•Ferulic acid was radiocaped with 131I− to explore its potential as a tumor targeting agent of plant origin.•Assessment of the radiochemical purity using miniaturized chromatographic techniques.</description><identifier>ISSN: 0969-8043</identifier><identifier>EISSN: 1872-9800</identifier><identifier>DOI: 10.1016/j.apradiso.2020.109370</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>131I-ferulic acid ; Anticancer ; Miniaturized chromatography ; Radiopharmaceuticals</subject><ispartof>Applied radiation and isotopes, 2021-01, Vol.167, p.109370-109370, Article 109370</ispartof><rights>2020 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c275t-f60ae3d70cb8da159150d957eab882e3ef435fda9a72b21d0694be9bb112c28a3</citedby><cites>FETCH-LOGICAL-c275t-f60ae3d70cb8da159150d957eab882e3ef435fda9a72b21d0694be9bb112c28a3</cites><orcidid>0000-0003-0323-2512</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0969804320305170$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Sedik, Ghada A.</creatorcontrib><creatorcontrib>Rizq, R.S. Abo</creatorcontrib><creatorcontrib>Ibrahim, I.T.</creatorcontrib><creatorcontrib>Elzanfaly, E.S.</creatorcontrib><creatorcontrib>Motaleb, M.A.</creatorcontrib><title>Miniaturized chromatographic systems for radiochemical purity evaluation of 131I-Ferulic acid as a new candidate in nuclear medicine applications</title><title>Applied radiation and isotopes</title><description>Recently, the anticancer activity of ferulic acid (FA) which is a caffeic acid derivative has been reported. Therefore, in this study FA was radiocaped with 131I− to explore its potential as a tumor targeting agent. The radiolabeling process was carried out via electrophilic substitution reaction. The factors affecting labeling yield were optimized and the radiochemical purity (RCP) was assessed by various analytical techniques including paper chromatography (PC), thin layer chromatography (TLC), instant thin layer chromatography (ITLC), paper electrophoresis (PE) and high-performance liquid chromatography (HPLC). The RCP assay was extended to the utilization of miniaturized techniques including miniaturized PC (mini-PC), mini-TLC and mini-column chromatography (silica, sephadex-G25). Validation of mini-TLC, as one of 131I-FA RCP assay methods, was done according to ICH guidelines. Biodistribution studies of 131I-FA were performed on Ehrlich solid tumor bearing mice at various time points (5, 30, 60, 120 and 240 min), post injection. The radiolabeling yield of 131I-FA was 96.23 ± 0.45% and the miniaturized chromatographic systems showed high efficacy in RCP evaluation comparable to the conventional ones. Mini-TLC was proved to be specific, accurate, precise and linear. The tumor uptake of 131I-FA in solid tumor bearing mice was 4.35 ± 0.41 ID/g at 60 min with 2.79 as a tumor/muscle ratio. Consequently, 131I-FA could be used as a tumor targeting agent for nuclear medicine applications and the fast reaction monitoring could be achieved using miniaturized chromatographic techniques. •Cancer is a class of diseases designated by uncontrolled cell growth.•For cancer treatment, different therapies are available. Chemotherapy and radiotherapy are the most common ones.•New trends to discover natural alternative therapies, especially from plants, are applied for cancer treatment.•Ferulic acid was radiocaped with 131I− to explore its potential as a tumor targeting agent of plant origin.•Assessment of the radiochemical purity using miniaturized chromatographic techniques.</description><subject>131I-ferulic acid</subject><subject>Anticancer</subject><subject>Miniaturized chromatography</subject><subject>Radiopharmaceuticals</subject><issn>0969-8043</issn><issn>1872-9800</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkU1v1DAQhi0EEkvhLyAfuWSxnS_7BqpoqdSqFzhbE3vCziqxg-0ULf-Cf0yWhTOnkUbv845GD2NvpdhLIbv3xz0sCTzluFdCnZem7sUztpO6V5XRQjxnO2E6U2nR1C_Zq5yPQohGG7Vjvx4oEJQ10U_03B1SnKHEbwmWAzmeT7ngnPkYEz-fiO6AMzmY-LIR5cTxCaYVCsXA48hlLe-qG0zrtLHgyHPIHHjAH9xB8OShIKfAw-omhMRn9OQoIIdl2ZA_Pfk1ezHClPHN33nFvt58-nL9ubp_vL27_nhfOdW3pRo7AVj7XrhBe5Ctka3wpu0RBq0V1jg2dTt6MNCrQUkvOtMMaIZBSuWUhvqKvbv0Lil-XzEXO1N2OE0QMK7ZqqaVuulUrbZod4m6FHNOONol0QzpZKWwZwf2aP85sGcH9uJgAz9cQNweeSJMNjvC4La_E7pifaT_VfwGXZSW7g</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Sedik, Ghada A.</creator><creator>Rizq, R.S. Abo</creator><creator>Ibrahim, I.T.</creator><creator>Elzanfaly, E.S.</creator><creator>Motaleb, M.A.</creator><general>Elsevier Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0323-2512</orcidid></search><sort><creationdate>202101</creationdate><title>Miniaturized chromatographic systems for radiochemical purity evaluation of 131I-Ferulic acid as a new candidate in nuclear medicine applications</title><author>Sedik, Ghada A. ; Rizq, R.S. Abo ; Ibrahim, I.T. ; Elzanfaly, E.S. ; Motaleb, M.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c275t-f60ae3d70cb8da159150d957eab882e3ef435fda9a72b21d0694be9bb112c28a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>131I-ferulic acid</topic><topic>Anticancer</topic><topic>Miniaturized chromatography</topic><topic>Radiopharmaceuticals</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sedik, Ghada A.</creatorcontrib><creatorcontrib>Rizq, R.S. Abo</creatorcontrib><creatorcontrib>Ibrahim, I.T.</creatorcontrib><creatorcontrib>Elzanfaly, E.S.</creatorcontrib><creatorcontrib>Motaleb, M.A.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Applied radiation and isotopes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sedik, Ghada A.</au><au>Rizq, R.S. Abo</au><au>Ibrahim, I.T.</au><au>Elzanfaly, E.S.</au><au>Motaleb, M.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Miniaturized chromatographic systems for radiochemical purity evaluation of 131I-Ferulic acid as a new candidate in nuclear medicine applications</atitle><jtitle>Applied radiation and isotopes</jtitle><date>2021-01</date><risdate>2021</risdate><volume>167</volume><spage>109370</spage><epage>109370</epage><pages>109370-109370</pages><artnum>109370</artnum><issn>0969-8043</issn><eissn>1872-9800</eissn><abstract>Recently, the anticancer activity of ferulic acid (FA) which is a caffeic acid derivative has been reported. Therefore, in this study FA was radiocaped with 131I− to explore its potential as a tumor targeting agent. The radiolabeling process was carried out via electrophilic substitution reaction. The factors affecting labeling yield were optimized and the radiochemical purity (RCP) was assessed by various analytical techniques including paper chromatography (PC), thin layer chromatography (TLC), instant thin layer chromatography (ITLC), paper electrophoresis (PE) and high-performance liquid chromatography (HPLC). The RCP assay was extended to the utilization of miniaturized techniques including miniaturized PC (mini-PC), mini-TLC and mini-column chromatography (silica, sephadex-G25). Validation of mini-TLC, as one of 131I-FA RCP assay methods, was done according to ICH guidelines. Biodistribution studies of 131I-FA were performed on Ehrlich solid tumor bearing mice at various time points (5, 30, 60, 120 and 240 min), post injection. The radiolabeling yield of 131I-FA was 96.23 ± 0.45% and the miniaturized chromatographic systems showed high efficacy in RCP evaluation comparable to the conventional ones. Mini-TLC was proved to be specific, accurate, precise and linear. The tumor uptake of 131I-FA in solid tumor bearing mice was 4.35 ± 0.41 ID/g at 60 min with 2.79 as a tumor/muscle ratio. Consequently, 131I-FA could be used as a tumor targeting agent for nuclear medicine applications and the fast reaction monitoring could be achieved using miniaturized chromatographic techniques. •Cancer is a class of diseases designated by uncontrolled cell growth.•For cancer treatment, different therapies are available. Chemotherapy and radiotherapy are the most common ones.•New trends to discover natural alternative therapies, especially from plants, are applied for cancer treatment.•Ferulic acid was radiocaped with 131I− to explore its potential as a tumor targeting agent of plant origin.•Assessment of the radiochemical purity using miniaturized chromatographic techniques.</abstract><pub>Elsevier Ltd</pub><doi>10.1016/j.apradiso.2020.109370</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-0323-2512</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0969-8043
ispartof Applied radiation and isotopes, 2021-01, Vol.167, p.109370-109370, Article 109370
issn 0969-8043
1872-9800
language eng
recordid cdi_proquest_miscellaneous_2451846232
source ScienceDirect Journals (5 years ago - present)
subjects 131I-ferulic acid
Anticancer
Miniaturized chromatography
Radiopharmaceuticals
title Miniaturized chromatographic systems for radiochemical purity evaluation of 131I-Ferulic acid as a new candidate in nuclear medicine applications
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T21%3A15%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Miniaturized%20chromatographic%20systems%20for%20radiochemical%20purity%20evaluation%20of%20131I-Ferulic%20acid%20as%20a%20new%20candidate%20in%20nuclear%20medicine%20applications&rft.jtitle=Applied%20radiation%20and%20isotopes&rft.au=Sedik,%20Ghada%20A.&rft.date=2021-01&rft.volume=167&rft.spage=109370&rft.epage=109370&rft.pages=109370-109370&rft.artnum=109370&rft.issn=0969-8043&rft.eissn=1872-9800&rft_id=info:doi/10.1016/j.apradiso.2020.109370&rft_dat=%3Cproquest_cross%3E2451846232%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2451846232&rft_id=info:pmid/&rft_els_id=S0969804320305170&rfr_iscdi=true